Press Release

12 December 2011

LIDCO GROUP PLC

("LiDCO" or the "Company")

Exercise of a Share Option

LiDCO Group Plc (AIM:LID), the UK-based hemodynamic monitoring company, announces that further to the exercise of a share option by an employee, 100,000 new ordinary shares of 0.5p each in the Company ("New Ordinary Shares") have been issued.

Application has been made for 100,000 New Ordinary Shares to be admitted to trading on AIM, which will rank pari passuwith Company's existing Ordinary Shares, and admission is expected to become effective on 13 December 2011 ("Admission").

Following admission of the New Ordinary Shares, the Company will have 174,220,304 Ordinary Shares in issue with each share carrying the right to one vote.  There are no shares held in Treasury.  The total number of voting rights in LiDCO is therefore 174,220,304.  This number may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or a change in their interest in, LiDCO, under the Disclosure and Transparency Rules.

- Ends -

For further information, please contact:

LiDCO Group Plc


Terry O'Brien (CEO)

Tel: +44 (0)20 7749 1500

Paul Clifford (Finance Director)


John Rowland (Company Secretary)                                        

FinnCap


Geoff Nash / Henrik Persson  

Stephen Norcross (broking)

Media enquiries:

Abchurch


Adam Michael / Joanne Shears /

Jamie Hooper

Tel: +44 (0) 20 7398 7719

jamie.hooper@abchurch-group.com

About LiDCO Group Plc

LiDCO is a supplier of minimally invasive hemodynamic equipment to hospitals, to monitor the amount of blood flowing around the body and ensure that vital organs are adequately oxygenated. LiDCO's products facilitate the application of hemodynamic optimization protocols for high risk patients in both critical care units and in the operating theatre.

Increasingly clinical studies are showing that the optimization of patients' hemodynamic status in high risk patients produces better outcomes and reduced hospital stay.  LiDCO's computer-based technology, developed at St Thomas' Hospital in London, has been shown to significantly reduce morbidity and complications, length of stay and overall costs associated with major surgery.

Key Products:

LiDCOplus: a computer-based platform monitor used in the Intensive Care Unit for real-time continuous display of hemodynamic parameters including cardiac output, oxygen delivery and fluid-volume responsiveness (PPV% and SVV%)

LiDCOrapid: a cardiac output monitor designed specifically for use in the operating theatre for fluid and drug management. The monitor enables anesthetists to get accurate and immediate feedback on the patient's fluid and hemodynamic status - a key measure of overall well-being before, during and after surgery.  The LiDCOrapidprovides:

· 

early and rapid warning of hemodynamic change to aid choice of therapeutic route: fluid or drug

· 

quantification of hemodynamic response,

· 

guidance on effective delivery of fluids to ensure the right amount at the right time

LiDCOview: an easy-to-use graphical display of historical LiDCOplusand LiDCOrapidhemodynamic data.

All LiDCO monitors use single-patient disposables (sensors or smartcards) which provide an ongoing revenue stream. 

Clinical Validation & Education

LiDCO has been selected as the sole technology for two ongoing multi-centre government-funded studies in the UK and US. OPTIMISE is sponsored by the UK Government for optimizing cardiovascular management in high-risk abdominal surgery patients and in the US, MOnIToR is a US Government sponsored transplantation donor organ optimization study. The Company has also developed a hemodynamic workshop atSt George's Hospital, London.

LiDCO Distribution Network:

LiDCO's strategy is to sell directly to hospitals in the UK, and through a network of specialty critical care and anesthesia distributors in the rest of the world.

LiDCO's sales office is in Cambridge, its manufacturing facility and headquarters are in London and its shares are traded on AIM..

distribué par

Ce noodl a été diffusé par LIDCO Group plc et initialement mise en ligne sur le site http://www.lidco.com. La version originale est disponible ici.

Ce noodl a été distribué par noodls dans son format d'origine et sans modification sur 2011-12-12 16:04:51 PM et restera accessible depuis ce lien permanent.

Cette annonce est protégée par les règles du droit d'auteur et toute autre loi applicable, et son propriétaire est seul responsable de sa véracité et de son originalité.